pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2008-0-2-105-110pulmo-1782Research ArticleОБЗОРЫREVIEWСтремление к контролю астмы: новые данные исследования GOALStriving for asthma control: new results of GOAL studyОгородоваЛ. М.OgorodovaL. M.
кафедра факультетской педиатрии с курсом детских болезней лечебного факультета
г. Томск
ПетровскийФ. И.PetrovskyF. I.
кафедра клинической иммунологии и аллергологии
г. Ханты-Мансийск
Сибирский ГМУRussian FederationХанты-Мансийский государственный медицинский институтRussian Federation20082804200802105110Copyright © Огородова Л.М., Петровский Ф.И., 20082008Огородова Л.М., Петровский Ф.И.Ogorodova L.M., Petrovsky F.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/1782
.
.
ReferencesBateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am. J. Respir. Crit. Care Med. 2004; 170: 836–844.Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am. J. Respir. Crit. Care Med. 2004; 170: 836–844.Pedersen S., Bateman E., Bousquet J. et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control Study. Allergy Clin. Immunol. 2007; 120: 1036–1042.Pedersen S., Bateman E., Bousquet J. et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma Control Study. Allergy Clin. Immunol. 2007; 120: 1036–1042.Bateman E., Clark T., Frith L. et al. Rate of response of Individual asthma control measures varies and may overestimate asthma control: an analysis of the GOAL Study. J. Asthma 2007; 44: 667–673.Bateman E., Clark T., Frith L. et al. Rate of response of Individual asthma control measures varies and may overestimate asthma control: an analysis of the GOAL Study. J. Asthma 2007; 44: 667–673.Огородова Л.М., Петровский Ф.И. Стремление к полному контролю бронхиальной астмы: обсуждение актуальных вопросов. Рос. аллергол. журн. 2006; 2: 53–59.Огородова Л.М., Петровский Ф.И. Стремление к полному контролю бронхиальной астмы: обсуждение актуальных вопросов. Рос. аллергол. журн. 2006; 2: 53–59.Цой А.Н., Архипов В.В. Контроль над бронхиальной астмой: каким он будет завтра? Исследование GOAL. Пульмонология 2004; 4: 92–104.Цой А.Н., Архипов В.В. Контроль над бронхиальной астмой: каким он будет завтра? Исследование GOAL. Пульмонология 2004; 4: 92–104.Woolcock A.J. What are the important questions in the treatment of asthma? Clin. Exp. Allergy Rev. 2001; 1: 62–64.Woolcock A.J. What are the important questions in the treatment of asthma? Clin. Exp. Allergy Rev. 2001; 1: 62–64.Reddel H.K., Jenkins C.R., Marks G.B. et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur. Respir. J. 2000; 16 (2): 226–235.Reddel H.K., Jenkins C.R., Marks G.B. et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur. Respir. J. 2000; 16 (2): 226–235.Global Initiative for Asthma Workshop Report 2007 [Электронный ресурс]. – Электрон. дан. – Режим доступа: http://www.ginasthma.com/Global Initiative for Asthma Workshop Report 2007 [Электронный ресурс]. – Электрон. дан. – Режим доступа: http://www.ginasthma.com/Ward С., Pais М., Bish R. et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57: 309–316.Ward С., Pais М., Bish R. et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57: 309–316.Woodcock A.A., Bagdonas A., Boonsawat W. et al. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. Prim. Care Respir. J. 2007; 16 (3): 155–161.Woodcock A.A., Bagdonas A., Boonsawat W. et al. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. Prim. Care Respir. J. 2007; 16 (3): 155–161.De Blic J., Poterre M., Attali V. et al. Salmeterol/fluticasone propionate is superior to doubling the dose of fluticasone propionate in children with asthma. In: The XXVI Congress of the European Academy of Allergology and Clinical Immunology (EAACI), Goteborg, Sweden, 9–13 June 2007.De Blic J., Poterre M., Attali V. et al. Salmeterol/fluticasone propionate is superior to doubling the dose of fluticasone propionate in children with asthma. In: The XXVI Congress of the European Academy of Allergology and Clinical Immunology (EAACI), Goteborg, Sweden, 9–13 June 2007.
The authors declare that there are no conflicts of interest present.